Annual Total Debt
$108.49 M
+$57.82 M+114.11%
December 31, 2024
Summary
- As of March 13, 2025, RXRX annual total debt is $108.49 million, with the most recent change of +$57.82 million (+114.11%) on December 31, 2024.
- During the last 3 years, RXRX annual total debt has risen by +$97.01 million (+845.22%).
- RXRX annual total debt is now at all-time high.
Performance
RXRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$108.49 M
+$17.87 M+19.72%
December 31, 2024
Summary
- As of March 13, 2025, RXRX quarterly total debt is $108.49 million, with the most recent change of +$17.87 million (+19.72%) on December 31, 2024.
- Over the past year, RXRX quarterly total debt has increased by +$17.87 million (+19.72%).
- RXRX quarterly total debt is now at all-time high.
Performance
RXRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RXRX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +114.1% | +19.7% |
| 3 y3 years | +845.2% | +19.7% |
| 5 y5 years | +571.0% | +19.7% |
RXRX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +845.2% | at high | +845.2% |
| 5 y | 5-year | at high | +845.2% | at high | -100.0% |
| alltime | all time | at high | +845.2% | at high | -100.0% |
Recursion Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $108.49 M(+114.1%) | $108.49 M(+19.7%) |
| Sep 2024 | - | $90.63 M(+0.8%) |
| Jun 2024 | - | $89.88 M(+76.3%) |
| Mar 2024 | - | $50.97 M(+0.6%) |
| Dec 2023 | $50.67 M(-0.7%) | $50.67 M(-1.6%) |
| Sep 2023 | - | $51.48 M(-2.7%) |
| Jun 2023 | - | $52.90 M(-0.3%) |
| Mar 2023 | - | $53.05 M(+4.0%) |
| Dec 2022 | $51.01 M | $51.01 M(-2.3%) |
| Sep 2022 | - | $52.19 M(-2.8%) |
| Jun 2022 | - | $53.68 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $52.10 M(+354.0%) |
| Dec 2021 | $11.48 M(-26.7%) | $11.48 M(+104.2%) |
| Sep 2021 | - | $5.62 M(-63.7%) |
| Jun 2021 | - | $15.48 M(-0.3%) |
| Mar 2021 | - | $15.54 M(-0.8%) |
| Dec 2020 | $15.66 M(-3.1%) | - |
| Dec 2020 | - | $15.66 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $16.17 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual total debt year-on-year change?
- What is Recursion Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly total debt year-on-year change?
What is Recursion Pharmaceuticals annual total debt?
The current annual total debt of RXRX is $108.49 M
What is the all time high annual total debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total debt is $108.49 M
What is Recursion Pharmaceuticals annual total debt year-on-year change?
Over the past year, RXRX annual total debt has changed by +$57.82 M (+114.11%)
What is Recursion Pharmaceuticals quarterly total debt?
The current quarterly total debt of RXRX is $108.49 M
What is the all time high quarterly total debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total debt is $108.49 M
What is Recursion Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, RXRX quarterly total debt has changed by +$17.87 M (+19.72%)